Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy

Transplant Proc. 1993 Feb;25(1 Pt 1):550-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Follow-Up Studies
  • Graft Rejection*
  • Humans
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Muromonab-CD3 / adverse effects
  • Muromonab-CD3 / therapeutic use*
  • Prospective Studies
  • Transplantation, Homologous

Substances

  • Muromonab-CD3